Strain-specific protective immunity following vaccination against experimental Trypanosoma cruzi infection

Vaccine

Volumn 27, Issue 41, 2009, Pages 5644-5653

  Haolla, Filipe A ^a   Claser, Carla ^a   de Alencar, Bruna C G ^a   Tzelepis, Fanny ^a   de Vasconcelos, José Ronnie ^a   de Oliveira, Gabriel ^b   Silvério, Jaline C ^b   Machado, Alexandre V ^b   Lannes Vieira, Joseli ^b   Bruna Romero, Oscar ^c   Gazzinelli, Ricardo T ^b,c,d   dos Santos, Ricardo Ribeiro ^b,e   Soares, Milena B P ^b,e   Rodrigues, Mauricio M ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^e HOSPITAL SÃO RAFAEL   (Brazil)

Author keywords

Adenovirus vaccine; CD8; DNA vaccine; Trypanosoma cruzi

Indexed keywords

ADENOVIRUS VECTOR; EPITOPE; PLASMID DNA; TRYPANOSOMA CRUZI VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ARTICLE; C57BL 6 MOUSE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHAGAS DISEASE; CONTROLLED STUDY; ELECTRIC CONDUCTIVITY; EXPERIMENTAL INFECTION; FEMALE; GENETIC IMMUNIZATION; HEART MUSCLE POTENTIAL; HEART RATE; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; LETHAL DOSE; MOUSE; MOUSE STRAIN; NONHUMAN; P WAVE; PARASITEMIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTOZOAL GENETICS; QRS COMPLEX; QT INTERVAL; TRYPANOSOMA CRUZI; TRYPOMASTIGOTE; VALIDATION STUDY;

ANIMALS; ANTIBODIES, PROTOZOAN; BASE SEQUENCE; CHAGAS DISEASE; CROSS REACTIONS; EPITOPES, T-LYMPHOCYTE; FEMALE; GLYCOPROTEINS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; NEURAMINIDASE; PARASITEMIA; PROTOZOAN VACCINES; SEQUENCE ALIGNMENT; SURVIVAL ANALYSIS; T-LYMPHOCYTES; TRYPANOSOMA CRUZI; VACCINES, DNA;

EID: 68949190917     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.07.013     Document Type: Article

References (53)

1. Garg N., and Bhatia V. Current status and future prospects for a vaccine against American trypanosomiasis. Expert Rev Vaccines 4 December (6) (2005) 867-880
2. Dumonteil E. DNA vaccines against protozoan parasites: advances and challenges. J Biomed Biotechnol 2007 6 (2007) 90520
3. Tarleton R.L. Immune system recognition of Trypanosoma cruzi. Curr Opin Immunol 19 August (4) (2007) 430-434
4. Martin D., and Tarleton R. Generation, specificity, and function of CD8+ T cells in Trypanosoma cruzi infection. Immunol Rev 201 October (2004) 304-317
5. Rodrigues M.M., Alencar B.C., Claser C., and Tzelepis F. Immunodominance: a new hypothesis to explain parasite escape and host/parasite equilibrium leading to the chronic phase of Chagas' disease?. Braz J Med Biol Res 42 March (3) (2009) 220-223
6. + T cell-dependent protective immunity against a human parasite (Trypanosoma cruzi) elicited by a heterologous plasmid DNA prime-recombinant adenovirus 5 boost vaccination; Infect Immun 2009 (in press).
7. Grebe K.M., Yewdell J.W., and Bennink J.R. Heterosubtypic immunity to influenza A virus: where do we stand?. Microbes Infect 10 July (9) (2008) 1024-1029
8. Tzelepis F., de Alencar B.C., Penido M.L., Gazzinelli R.T., Persechini P.M., and Rodrigues M.M. Distinct kinetics of effector CD8+ cytotoxic T cells after infection with Trypanosoma cruzi in naive or vaccinated mice. Infect Immun 74 April (4) (2006) 2477-2481
9. Martin D.L., Weatherly D.B., Laucella S.A., Cabinian M.A., Crim M.T., Sullivan S., et al. CD8+ T-Cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes. PLoS Pathog 2 August (8) (2006) e77
10. Tzelepis F., de Alencar B.C., Penido M.L., Claser C., Machado A.V., Bruna-Romero O., et al. Infection with Trypanosoma cruzi restricts the repertoire of parasite-specific CD8+ T cells leading to immunodominance. J Immunol 180 February (3) (2008) 1737-1748
11. Claser C., Espíndola N.M., Sasso G., Vaz A.J., Boscardin S.B., and Rodrigues M.M. Immunologically relevant strain polymorphism in the amastigote surface protein 2 of Trypanosoma cruzi. Microbes Infect 9 July (8) (2007) 1011-1019
12. Dost C.K., Albuquerque S., Hemleben V., Engels W., and Prado Jr. J.C. Molecular genetic characterization of different Trypanosoma cruzi strains and comparison of their development in Mus musculus and Calomys callosus. Parasitol Res 88 July (7) (2002) 609-616
13. Frederici E.E., Albelmann W.B., and Neva F.A. Chronic and progressive, 1964. Myocarditis and myositis in C3H mice infected with Trypanosoma cruzi. Am J Trop Med Hyg 13 March (1964) 272-280
14. Briones M.R., Souto R.P., Stolf B.S., and Zingales B. The evolution of two Trypanosoma cruzi subgroups inferred from rRNA genes can be correlated with the interchange of American mammalian faunas in the Cenozoic and has implications to pathogenicity and host specificity. Mol Biochem Parasitol 104 November (2) (1999) 219-232
15. Boscardin S.B., Kinoshita S.S., Fujimura A.E., and Rodrigues M.M. Immunization with cDNA expressed by amastigotes of Trypanosoma cruzi elicits protective immune response against experimental infection. Infect Immun 71 May (5) (2003) 2744-2757
16. Costa F., Franchin G., Pereira-Chioccola V.L., Ribeirão M., Schenkman S., and Rodrigues M.M. Immunization with a plasmid DNA containing the gene of trans-sialidase reduces Trypanosoma cruzi infection in mice. Vaccine 16 May (8) (1998) 768-774
17. Machado A.V., Cardoso J.E., Claser C., Rodrigues M.M., Gazzinelli R.T., and Bruna-Romero O. Long-term protective immunity induced against Trypanosoma cruzi infection after vaccination with recombinant adenoviruses encoding amastigote surface protein-2 and trans-sialidase. Hum Gene Ther 17 September (9) (2006) 898-908
18. Araújo A.F., de Alencar B.C., Vasconcelos J.R., Hiyane M.I., Marinho C.R., Penido M.L., et al. CD8+-T-cell-dependent control of Trypanosoma cruzi infection in a highly susceptible mouse strain after immunization with recombinant proteins based on amastigote surface protein 2. Infect Immun 73 September (9) (2005) 6017-6025
19. de Alencar B.C., Araújo A.F., Penido M.L., Gazzinelli R.T., and Rodrigues M.M. Cross-priming of long lived protective CD8+ T cells against Trypanosoma cruzi infection: importance of a TLR9 agonist and CD4+ T cells. Vaccine 25 August (32) (2007) 6018-6027
20. Giddings O.K., Eickhoff C.S., Smith T.J., Bryant L.A., and Hoft D.F. Anatomical route of invasion and protective mucosal immunity in Trypanosoma cruzi conjunctival infection. Infect Immun 74 October (10) (2006) 5549-5560
21. Hoft D.F., Eickhoff C.S., Giddings O.K., Vasconcelos J.R., and Rodrigues M.M. Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic Trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming. J Immunol 179 November (10) (2007) 6889-6900
22. Yoshida N. Surface antigens of metacyclic trypomastigotes of Trypanosoma cruzi. Infect Immun 40 May (2) (1983) 836-839
23. Garg N., and Tarleton R.L. Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection. Infect Immun 70 October (10) (2002) 5547-5555
24. Vasconcelos J.R., Hiyane M.I., Marinho C.R., Claser C., Machado A.M., Gazzinelli R.T., et al. Protective immunity against Trypanosoma cruzi infection in a highly susceptible mouse strain after vaccination with genes encoding the amastigote surface protein-2 and trans-sialidase. Hum Gene Ther 15 September (9) (2004) 878-886
25. Fujimura A.E., Kinoshita S.S., Pereira-Chioccola V.L., and Rodrigues M.M. DNA sequences encoding CD4+ and CD8+ T-cell epitopes are important for efficient protective immunity induced by DNA vaccination with a Trypanosoma cruzi gene. Infect Immun 69 September (9) (2001) 5477-5486
26. Vasconcelos J.R., Boscardin S.B., Hiyane M.I., Kinoshita S.S., Fujimura A.E., and Rodrigues M.M. A DNA-priming protein-boosting regimen significantly improves type 1 immune response but not protective immunity to Trypanosoma cruzi infection in a highly susceptible mouse strain. Immunol Cell Biol 81 April (2) (2003) 121-129
27. Boni M.F. Vaccination and antigenic drift in influenza. Vaccine 26 July (Suppl. 3) (2008) C8-C14 Review
28. Dagan R. Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae. Clin Microbiol Infect 15 April (Suppl. 3) (2009) 16-20
29. Pattaradilokrat S., Cheesman S.J., and Carter R. Linkage group selection: towards identifying genes controlling strain specific protective immunity in malaria. PLoS ONE 2 September (9) (2007) e857
30. Wijayalath W.A., Cheesman S., Rajakaruna J., Handunnetti S.M., Carter R., and Pathirana P.P. Evidence for strain-specific protective immunity against blood-stage parasites of Plasmodium cynomolgi in toque monkey. Parasite Immunol 30 November-December (11-12) (2008) 630-636
31. Crewther P.E., Matthew M.L., Flegg R.H., and Anders R.F. Protective immune responses to apical membrane antigen 1 of Plasmodium chabaudi involve recognition of strain-specific epitopes. Infect Immun 64 August (8) (1996) 3310-3317
32. Flück C., Smith T., Beck H.P., Irion A., Betuela I., Alpers M.P., et al. Strain-specific humoral response to a polymorphic malaria vaccine. Infect Immun 72 November (11) (2004) 6300-6305
33. Lyon J.A., Angov E., Fay M.P., Sullivan J.S., Girourd A.S., Robinson S.J., et al. Protection induced by Plasmodium falciparum MSP1(42) is strain-specific, antigen and adjuvant dependent, and correlates with antibody responses. PLoS ONE 3 July (7) (2008) e2830
34. Hyland K.V., Asfaw S.H., Olson C.L., Daniels M.D., and Engman D.M. Bioluminescent imaging of Trypanosoma cruzi infection. Int J Parasitol 38 October (12) (2008) 1391-1400
35. Leavey J.K., and Tarleton R.L. Cutting edge: dysfunctional CD8+ T cells reside in nonlymphoid tissues during chronic Trypanosoma cruzi infection. J Immunol 170 March (5) (2003) 2264-2268
36. dos Santos R.R., Rossi M.A., Laus J.L., Silva J.S., Savino W., and Mengel J. Anti-CD4 abrogates rejection and reestablishes long-term tolerance to syngeneic newborn hearts grafted in mice chronically infected with Trypanosoma cruzi. J Exp Med 175 January (1) (1992) 29-39
37. Soares M.B., Silva-Mota K.N., Lima R.S., Bellintani M.C., Pontes-de-Carvalho L., and Ribeiro-dos-Santos R. Modulation of chagasic cardiomyopathy by interleukin-4: dissociation between inflammation and tissue parasitism. Am J Pathol 159 August (2) (2001) 703-709
38. Michailowsky V., Silva N.M., Rocha C.D., Vieira L.Q., Lannes-Vieira J., and Gazzinelli R.T. Pivotal role of interleukin-12 and interferon-gamma axis in controlling tissue parasitism and inflammation in the heart and central nervous system during Trypanosoma cruzi infection. Am J Pathol 159 November (5) (2001) 1723-1733
39. Camandaroba E., Thé T.S., Pessina D.H., and Andrade S.G. Trypanosoma cruzi: clones isolated from the Colombian strain, reproduce the parental strain characteristics, with ubiquitous histotropism. Int J Exp Pathol 87 June (3) (2006) 209-217
40. Rocha N.N., Garcia S., Giménez L.E., Hernández C.C., Senra J.F., Lima R.S., et al. Characterization of cardiopulmonary function and cardiac muscarinic and adrenergic receptor density adaptation in C57BL/6 mice with chronic Trypanosoma cruzi infection. Parasitology 133 December (Pt 6) (2006) 729-737
41. Medeiros G.A., Silvério J.C., Marino A.P., Roffê E., Vieira V., Kroll-Palhares K., et al. Treatment of chronically Trypanosoma cruzi-infected mice with a CCR1/CCR5 antagonist (Met-RANTES) results in amelioration of cardiac tissue damage. Microbes Infect 11 February (2) (2009) 264-273
42. Sales Jr. P.A., Golgher D., Oliveira R.V., Vieira V., Arantes R.M., Lannes-Vieira J., et al. The regulatory CD4+CD25+ T cells have a limited role on pathogenesis of infection with Trypanosoma cruzi. Microbes Infect 10 May (6) (2008) 680-688
43. Punukollu G., Gowda R.M., Khan I.A., Navarro V.S., and Vasavada B.C. Clinical aspects of the Chagas' heart disease. Int J Cardiol 115 February (3) (2007) 279-283
44. Kroll-Palhares K., Silvério J.C., Silva A.A., Michailowsky V., Marino A.P., Silva N.M., et al. TNF/TNFR1 signaling up-regulates CCR5 expression by CD8+ T lymphocytes and promotes heart tissue damage during Trypanosoma cruzi infection: beneficial effects of TNF-alpha blockade. Mem Inst Oswaldo Cruz 103 June (4) (2008) 375-385
45. Chandra M., Tanowitz H.B., Petkova S.B., Huang H., Weiss L.M., Wittner M., et al. Significance of inducible nitric oxide synthase in acute myocarditis caused by Trypanosoma cruzi (Tulahuen strain). Int J Parasitol 32 June (7) (2002) 897-905
46. Cardioprotective effects of verapamil on myocardial structure and function in a murine model of chronic Trypanosoma cruzi infection (Brazil Strain): an echocardiographic study.
47. Chandra M., Shirani J., Shtutin V., Weiss L.M., Factor S.M., Petkova S.B., et al. Int J Parasitol 32 February (2) (2002) 207-215
48. Caldas I.S., Talvani A., Caldas S., Carneiro C.M., de Lana M., da Matta Guedes P.M., et al. Benznidazole therapy during acute phase of Chagas disease reduces parasite load but does not prevent chronic cardiac lesions. Parasitol Res 103 July (2) (2008) 413-421
49. Sanchez J.A., Milei J., Yu Z.X., Storino R., Wenthold Jr. R., and Ferrans V.J. Immunohistochemical localization of laminin in the hearts of patients with chronic chagasic cardiomyopathy: relationship to thickening of basement membranes. Am Heart J 126 December (6) (1993) 1392-1401
50. Abdalla G.K., Faria G.E., Silva K.T., Castro E.C., Reis M.A., and Michelin M.A. Trypanosoma cruzi: the role of PGE2 in immune response during the acute phase of experimental infection. Exp Parasitol 118 April (4) (2008) 514-521
51. Garzoni L.R., Adesse D., Soares M.J., Rossi M.I., Borojevic R., and de Meirelles Mde N. Fibrosis and hypertrophy induced by Trypanosoma cruzi in a three-dimensional cardiomyocyte-culture system. J Infect Dis 197 March (6) (2008) 906-915
52. Muñoz N., Manalastas Jr. R., Pitisuttithum P., Tresukosol D., Monsonego J., Ault K., et al. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6,11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised double-blind trial. Lancet 373 June (9679) (2009) 1949-1957
53. Cazorla S.I., Frank F.M., and Malchiodi E.L. Vaccination approaches against Trypanosoma cruzi infection. Expert Rev Vaccines July (8) (2009) 921-935